Avalon Investment & Advisory Charles River Laboratories International, Inc. Transaction History

Avalon Investment & Advisory

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $153,709 - $227,707	-753 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$255.51 - $362.11 $9.06 Million - $12.8 Million	-35,465 Reduced 97.92%	753 $214,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $2.18 Million - $2.78 Million	-6,204 Reduced 14.62%	36,218 $13.6 Million
Q3 2021 Nov 08, 2021	BUY	$372.64 - $458.3 $781,426 - $961,055	2,097 Added 5.2%	42,422 $17.5 Million
Q2 2021 Jul 29, 2021	SELL	$294.17 - $371.65 $5.43 Million - $6.86 Million	-18,468 Reduced 31.41%	40,325 $14.9 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $57,923 - $69,479	232 Added 0.4%	58,793 $17 Million
Q4 2020 Feb 08, 2021	BUY	$222.0 - $252.62 $118,770 - $135,151	535 Added 0.92%	58,561 $14.6 Million
Q3 2020 Nov 04, 2020	SELL	$175.56 - $226.45 $444,166 - $572,918	-2,530 Reduced 4.18%	58,026 $13.1 Million
Q2 2020 Aug 07, 2020	SELL	$118.84 - $189.72 $880,366 - $1.41 Million	-7,408 Reduced 10.9%	60,556 $10.6 Million
Q1 2020 May 05, 2020	BUY	$98.9 - $178.34 $6.72 Million - $12.1 Million	67,964 New	67,964 $8.58 Million

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.